Teyi Pharmaceutical Group Co.,Ltd engages in the research and development, production, and sale of Chinese patented medicines, pharmaceutical preparations, raw...
Shanghai and Shenzhen A Shrs Midday Down 0.4% to 2.3%; Banks and Pharma Stocks Buck Trend
The A-shares opened lower and rose higher, with all three major indices turning positive. The chemical and electric grid sectors collectively surged, the Hang Seng Index fell over 1%, tech stocks continued to decline, and Shanghai silver dropped over 13%
February 6th Midday Review: ChiNext opened lower but rose to gain 0.65%, with chemical and robotics concept stocks collectively strengthening
Chinese medicine stocks opened sharply higher, with Panlong Pharmaceutical and TY PHAR. hitting the daily limit, and Bio Valley and LSPG rising over 10%
The three major A-share indices of Shanghai and Shenzhen opened lower by 0.9% to 1.2%, with oil and gold stocks weak, while traditional Chinese medicine stocks rose against the trend
TY PHAR. released its performance for the first three quarters, with a net profit attributable to the parent company of 65.2171 million yuan, a year-on-year increase of 985.18%